Dr Nabavi has actively involved in teaching and training of a variety of professionals concerning mental health disorders. In addition, he regularly supervises medical students attached to his clinical team, to whom he provides formal and informal teaching, as well as supervising them with their research and audit projects.

Dr Nabavi has also been involved in carrying out research in the fields of anxiety and mood disorders, psychopharmacology, treatment of psychoses and adult ADHD, as well as non-adherence and comorbidity. His research into a meta-analysis of the prevalence rate of comorbid anxiety disorders in bipolar affective disorders was awarded with the ‘Research Presentation Prize of 2014’ from the Royal College of Psychiatrists, West Midlands Division.

In the past two years, Dr Nabavi has published two peer-review papers, as well as presenting five posters in national and international meetings and conferences. In addition, within the last year, he has delivered more than 20 formal presentations in academic meetings and congresses.

1. Nabavi B., Lee R. The use of benzodiazepine in psychiatric inpatient settings. Estimated completion date: February 2017.
2. Nabavi B., Wagstaff A., Woodward S.  Examining the characteristic of patients on long-acting antipsychotic injection. Estimated completion date: March 2017.
3. Nabavi B., Farley C. Adherence to NICE guidelines in prescribing in adult ADHD. Estimated completion date: March 2017.
4. Nabavi B., Canbilen S., D’Costa J. Case Study: psychiatric presentations of a female patient with a 16p11.2 chromosomal rearrangement. Estimated completion date: March 2017.

1. B. Nabavi. Naturalistic study of patients on paliperidone palmitate in a mental health trust in England, October 2014.
2. B. Nabavi, V. Murali. A cross-sectional study: to estimate the prevalence rate of adult ADHD in substance use disorder, September 2014.
3. Nabavi SB, Mitchell AJ, Nutt D. A lifetime prevalence of comorbidity between bipolar affective disorder and anxiety disorders: A meta-analysis of 52 interview-based studies of outpatient/inpatient population, 2013-14.
4. Nabavi B (research facilitator). A multi-centred BALANCE trial, 2010.
5. Nabavi B. Clinical Survey: Obtaining the service users opinion on the overall quality of depot clinic, 2009.
6. Nabavi B. Clinical Survey: Physical Health of patients on Depot antipsychotic medications attending depot clinic, 2007.
7. Nabavi B. Clinical Survey: A survey on smoking by nursing staff in three hospitals in Northampton, 1999.
8. Seifalian AM, Doctor N, Nabavi B, Davidson BR. A new technique for monitoring hepatic microcirculation using implantable fibre optic, 1997.
9. Seifalian AM, Ogbeide S, Doctor N, Nabavi B, Davidson BR. Measurement of liver oxygenation by near infra-red spectroscopy, 1997.

1. Nabavi B, Mitchell AJ, Nutt D. A lifetime prevalence of comorbidity between bipolar affective disorder and anxiety disorders: A meta-analysis of 52 interview-based studies of psychiatric population, EBioMedicine, vol. 2, issue 10, p1405-1419. (2015).
2. Nabavi B. Case Notes: Aripiprazole long-acting injection (abilify maintena) in the management of adult patients with schizophrenia, Progress in Neurology and Psychiatry (Case Notes), P: 2-7; UK/AM/0814/0237, September 2014.
3. Nabavi B. Case report: Aripiprazole in first-episode psychosis. MIMS Advances in Schizophrenia; P: 6-7; Issue 3 June 2010.
4. Rahmanian HM, Nabavi B, Peivandi MH. Farsi Translation of Leaflet on Smoking and Mental Health. The Royal College of Psychiatrist, www.rcpsych.ac.uk/healthadvice/translations, September 2009.
5. Rahmanian HM, Nabavi B. Farsi Translation of Leaflet on Personality Disorder. The Royal College of Psychiatrist, www.rcpsych.ac.uk/healthadvice/translations, 2008.
6. Seifalian AM, Doctor N, Nabavi B, Davidson BR. A new technique for monitoring hepatic microcirculation using implantable fibre optic. HPB Surgery 1997; 1:7081.
7. Seifalian AM, Ogbeide S, Doctor N, Nabavi B, Davidson BR. Measurement of liver oxygenation by near infra-red spectroscopy. HPB Surgery 1997; 1: 7014.

1. Clinical Audit: A review of basic observations and physical examination of 100 consecutive inpatient cases at a psychiatric hospital, the Oleaster Centre, Birmingham, February 2016.
2. Clinical Audit: A completed audit and re-audit to reduce psychiatric outpatients’ non-attendance rates, Small Heath Health Centre, Birmingham, 2014.
3. Clinical Audit: A review of 50 medical reports for the First-Tier Tribunal, Hallam Street Hospital, West Bromwich, 2013.
4. Clinical Audit: Audit and re-audit of waiting times and referrals to the DSH Team, Leicester Royal Infirmary, 2012.
5. Clinical audit: Assessing Whether Local Mental Health Foundation Trust Guidelines are Adhered to in Regards to the Referral and Active Follow-Up of Service Users who do not Respond to Initial Contact from a CMHT, Ladywood CMHT, Birmingham, 2012.
6. Clinical Audit: A Review of Service Users Receiving a Copy of the Care Plan and Information on Treatment in the Home Treatment Service. Birmingham and Solihull Mental Health NHS Foundation Trust, Birmingham, 2010.
7. Clinical Audit: Review of Referral to Home Treatment Team within a two-year period, Small Heath Health Centre, Birmingham, 2009.
8. Clinical Audit: Review of 200 referrals to CLDT Teams in 2001, Learning Disabilities Teams within Bath & North-East Somerset PCT, 2002.
9. Clinical Audit: Review of risk assessment screen in 50 inpatients at a psychiatric hospital, Green Lane Hospital Devizes, Wiltshire, 1999.

1. Ghezelayagh S., Hayes J., Nabavi B. A review of basic observations and physical examination of 100 consecutive inpatient cases at a psychiatric hospital, presented at the Spring Meeting of the West Midlands Division of the Royal College of Psychiatrists, Birmingham, May 2016.
2. Burlington K, Brownell L, Anandakumar P, Nabavi B, Elswood M. Case Report: Combining clozapine with chemotherapy and stem cell transplant in a patient with treatment-resistant schizophrenia and AL amyloidosis, Presented at the Royal College of Psychiatrists’’ International Congress, Birmingham, June 2015.
3. Nabavi B. Naturalistic study of patients on paliperidone palmitate in a mental health trust in England, presented at ECNP (European Congress of Neuropsychopharmacology) Meeting, Berlin, October 2014.
4. Nabavi B, Nithiananthan K, Khan A. A completed audit and re-audit to reduce psychiatric outpatients’ non-attendance rates, Presented at General Adult Psychiatrists’’ Annual Meeting, Birmingham, October 2014.
5. Nabavi B, Murali V. A cross-sectional study: to estimate the prevalence rate of adult ADHD in substance use disorder, presented at the UKAAN International Congress, London, September 2014.
6. Nabavi B, El-Hilu S. A review of 50 medical reports for the First-Tier Tribunal, presented at the Spring Meeting of the West Midlands Division of the Royal College of Psychiatrists, Birmingham, May 2014.

1. ‘The overview of atypical LAIs in the long-term outcome in schizophrenia’, Formal Academic Meeting, Hallam Street Hospital, West Bromwich, 16 November 2016.
2. ‘ADHD and comorbidity, Professional Seminar for ADHD Specialists, Hinckley, Leicestershire, 13 October 2016.
3. ‘Optimising treatment in schizophrenia: overcoming the barriers’, Formal Academic Meeting, Taunton, Somerset 01 June 2016.
4. ‘The impact of LAIs in the long-term outcome in schizophrenia’, Greek Annual Psychiatrists Congress, Alexandropoulos, 14-17 April 2016.
5. ‘Optimising treatment in schizophrenia: overcoming the barriers’, Cornwall PGME, Newquay, 23 March 2016.
6. ‘Improving quality of life in schizophrenia’, Ealing Recovery East Team, London, 15 February 2016.
7. ‘The meta-analysis of lifetime comorbidity: bipolar and anxiety disorders’, 15^th International Forum of Mood and Anxiety Disorders, Prague, 02-04 December 2015.
8. ‘Long-acting Injection in Long-Term Treatment of Schizophrenia’, Formal Academic Meeting, Llandough General Hospital, Cardiff, 01 May 2015. 
9. ‘Non-Adherence in Schizophrenia: Evidence From a Local Naturalistic Study’, Formal Academic Meeting, Hellesdon Hospital, Norwich, 05 March 2015.
10. ‘Non-Adherence in Schizophrenia: Evidence from a local Naturalistic Study’, Formal Academic Meeting, Ipswich General Hospital, 12 February 2015.
11. ‘Non-Adherence in Schizophrenia: Evidence From a Local Naturalistic Study’, Formal Academic Meeting, Hallam Street Hospital, West Bromwich, 17 December 2014.
12. ‘Comorbidity between Bipolar Affective Disorder and Anxiety Disorders: Research Presentation’, Formal Psychiatric Academic Meeting, Worcester, 05 December 2014.
13. ‘Non-Adherence in Schizophrenia’, Psychiatrists’ Refreshing Meeting, Nottingham, 03 December 2014.
14. ‘Treatment Options for Optimising Long-term Patient Outcomes in Schizophrenia’, National Mental Health Outcomes Congress, London, 02 December 2014.
15. ‘Non-Adherence in Schizophrenia: Evidence From a Local Naturalistic Study’, Formal Academic Meeting, Penn Hospital, Wolverhampton, 21 November 2014.
16. ‘Treatment of Depressive and Anxiety Disorders in Primary Care’, GPs Refreshing Meeting, Birmingham, 16 September 2014.
17. ‘Lifetime Prevalence of comorbidity Between Bipolar Affective Disorder and Anxiety Disorders: A Meta-Analysis of 52 Interview-Based Studies of Outpatient/Inpatient Population’, The Spring Meeting of the West Midlands Division of the Royal College of Psychiatrists, 09 May 2014.
18. ‘HIV/AIDS and Psychiatric Disorders’, Leicester Royal Infirmary, 23 January 2014.
19. ‘Psychodermatology: Where the Mind and Skin Interacts’, Leicester Royal Infirmary, 17 May 2012.
20. ‘Anxiety in Practice Speaker Forum’ conference, Copenhagen, 11-12 February 2011.
21. ‘Pain and Anxiety Disorder-Breaking the Chain’, Birmingham Medical Institute, 01 October 2009.
22. ‘Treatment of Depression and Anxiety, Confronting Recent Challenges’, Beirut in 19 March 2009.
23. ‘Crisis Resolution Home Treatment Services’ NIKI International Collaboration, Tabriz University, Iran, 2008.
24. Measurement of liver oxygenation by near infrared spectroscopy. Hamburg, Germany: European I.H.P.B.A. Congress: 1997.
25. A new technique for monitoring hepatic microcirculation using implantable fibre optic. Hamburg, Germany: European I.H.P.B.A. Congress; 1997.

1. ‘ADHD, complexity and transition meeting’, Professional Seminar for ADHD Specialists, Birmingham, 08 July 2016.
2. ‘ADHD Workshop’, Professional Seminar for ADHD Nurse Prescribers, Crewe Hall, 08-09 June 2016.
3. ‘Life, Liberty and Pursuit of Happiness’, Psychiatric Teaching Meeting, NEC, Birmingham, 24 May 2016.
4. ‘Pharmacological Aspects of Treatment in Schizophrenia’, Round the table teaching and discussion, Leeds, 02 March 2016.
5. ‘Overview of Anxiety Disorder in Primary care’, GP Core Trainees Formal Teaching, West Midlands Rotation, Birmingham, 18 May 2015.
6. ‘Systematic Reviews and Meta-analyses Studies’, Psychiatry Core Trainees Formal Teaching, West Midlands, 29 January 2015.
7. ‘Introduction to Adult ADHD’, Academic Meeting, Northcroft Hospital, Birmingham, 30 April 2014.
8. ‘Comorbidity in Psychiatric Disorders: Research Presentation’, Consultant Psychiatrists Teaching Meeting, Birmingham, 28 April 2014.
9. ‘Systematic Reviews and Meta-analyses Studies’, Psychiatry Core Trainees Formal Teaching, West Midlands, 20 February 2014.
10. ‘Overview of Anxiety and Depressive Disorders’, Nurse Prescribers Formal Teaching, Leicester, 26 September 2013.
11. ‘Interview Skill Training’, Psychiatry Core Trainees Formal Teaching, Hallam Street Hospital, West Bromwich, 01 March 2013. 
12. ‘Systematic Reviews and Meta-analyses Studies’, Psychiatry Core Trainees Formal Teaching, West Midlands, 21 February 2013.
13. ‘Cross-Sectional Studies’, Academic Meeting, Hallam Street Hospital, West Bromwich, 20 February 2013.
14. ‘Liaison Psychiatry: Pain and Anxiety’ Leicester Medical School, 06 February 2012.
15. ‘Masterclass in Anxiety and Depression’ Grange Hall, Holmes Chapel, 23-25 November 2008.